Introduction {#Sec1}
============

The potential influence of psychological stress on type 1 diabetes (T1D) is well studied. Stress is associated with systemic immunological and hormonal changes that can alter the immunological balance to increase the risk of autoimmunity and T1D via a number of different mechanisms \[[@CR1]--[@CR4]\].

Elevated cortisol levels represent an acute response to stress that has immediate effects on both the immune system and metabolism \[[@CR5]--[@CR7]\]. Additionally, there are data supporting long-term effects of early elevated cortisol levels on the risk of immunological diseases and allergies \[[@CR8], [@CR9]\]. Cortisol also appears to have a direct effect on insulin resistance, adding to the strain on pancreatic beta cells \[[@CR10]\]. Children exposed to early life stress have been shown to have higher C-reactive protein levels than average as adults, and adults with a history of childhood abuse have higher levels of circulating pro-inflammatory cytokines than the general population \[[@CR9], [@CR11]\].

One distinct psychological stressor is a severe life event (SLE) such as a bereavement, serious family illness, family conflict, and socio-economic problems \[[@CR12]\]. Early SLEs have been linked to an increased risk of T1D and islet autoimmunity \[[@CR10], [@CR13]--[@CR15]\], although data are conflicting \[[@CR13]--[@CR15]\], with very young individuals apparently more vulnerable to the immunomodulatory effects of SLEs than older children and adults \[[@CR16]\]. A growing body of evidence proposes that the ability of the individual to cope with stress and adversity may also be affected by factors that can be estimated using quality of life or sense of coherence measures \[[@CR17], [@CR18]\]. A high quality of life/sense of coherence may, therefore, act as a buffer, decreasing the negative impact of the event(s).

The stress levels of infants and children are hard to quantify but have been found to be correlated with the stress levels of their parents. Furthermore, like many other risk factor studies, there is a long latency between exposure and T1D disease onset. Nevertheless, there are new data on the early stages of T1D development that indicate that very early factors associated with autoimmune processes leading to islet autoimmunity and eventually T1D are relevant \[[@CR19], [@CR20]\].

The Diabetes Prediction in Skåne (DiPiS) study is a prospective follow-up of children at risk of T1D in southern Sweden. Here, we investigated the effects of early-life family SLEs on the risk of T1D using questionnaire data recorded by parents when the child was between 2 months and 2 years of age. We also evaluated if children with the highest HLA-conferred risk (HLA DQ2/8) were more susceptible to stress compared to children with a lower genetic T1D risk.

Methods {#Sec2}
=======

The DiPiS study {#Sec3}
---------------

Between August 2000 and September 2004, 48,058 children were born in the five hospitals in the Skåne region in southern Sweden. 35,683 cord blood samples were collected at birth along with basic demographic data. Cord blood samples were analyzed for autoantibodies to glutamate decarboxylase 65 (GAD65A), insulin (IAA), insulinoma antigen 2 (IA-2A), and HLA-DQ genotype \[[@CR21], [@CR22]\]. At 2 months of age, parents of study participants were asked to complete a questionnaire regarding perinatal, hereditary, medical, and social factors, as well as if the parent had experienced an SLE during pregnancy or the child's first 2 months of life. 23,187 questionnaires with written consent for study participation were returned.

A basic risk model was developed accounting for HLA-conferred T1D risk, infections during pregnancy, deviating relative birth weight, affected first-degree relatives, and cord blood autoantibody positivity. Based on this risk model, 7826 participants were invited for follow-up, of whom 3784 accepted and returned a questionnaire at 2 years of age including information regarding medical history, psychosocial setting, parental SLEs, and questions regarding study participation during the child's first 2 years of life.

From the age of two, study participants were screened for islet autoantibodies and were administered questionnaires on a yearly basis. These questionnaires include a wide range of questions regarding the lives of the child and family including dietary factors, hospitalization, illness and medications, psychosocial factors, child care, disease in the immediate family, and whether any parent has experienced a severe life event. Participants who developed two or more positive autoantibodies were offered follow-up every 3 months with autoantibody analysis for GAD65A, IAA, IA-2A and three zinc transporter 8 (ZnT8A) isoforms, HbA1c, random plasma glucose, growth parameters, and annual oral glucose tolerance test. Data regarding T1D heredity were collected from both a form from the maternity department at birth and the 2-month and 2-year questionnaires, the questions asked being if the parent or siblings had diabetes and if they were treated with insulin. No follow-up question regarding the type of diabetes was asked at this time.

Insulin-dependent diabetes mellitus (IDDM) in a first-degree relative was defined as the mother, father, or any sibling being treated with insulin for diabetes. Mothers reported to have gestational diabetes or diabetes but not treated with insulin were excluded from the IDDM group. Incidence data regarding T1D were collected through the participating clinics and via the Better Diabetes Diagnosis (BDD) study, which covers approximately 95% of children diagnosed with T1D in Sweden \[[@CR23]\]. All children with answers to the 2-month and 2-year questionnaires were included in the study (Fig. [1](#Fig1){ref-type="fig"}).

Fig. 1Study inclusion flow chart

The study was approved by the Regional Ethics review board in Lund.

Severe life event analysis {#Sec4}
--------------------------

The 2-month questionnaire contained questions regarding life events during pregnancy and during the child's first 2 months of life. The question "Did you experience anything that you would consider to be a significant life event during pregnancy or after the child's birth?" was followed by eight options: "death of a close relative"; "severe disease in the family"; "serious accident in the family"; "own divorce or separation"; "been subjected to violence"; "lost employment"; "husband/partner lost employment"; "serious conflict with partner or other significant person". The same questions were repeated in the 2-year questionnaire.

Due to the relatively small number of events in each individual category, two larger combined variables were also analyzed for SLEs: (1) events of a more acute and sudden nature, including severe disease in the family, death of a close relative, serious accident in the family, or having experienced violence; and (2) SLEs of a lower intensity and possibly longer duration including divorce in the family, either parent becoming unemployed, or divorce of the parents.

All SLEs during pregnancy were analyzed as a separate outcome. For SLEs after birth during the child's first 2 years of life, the answers from the 2-month and 2-year questionnaires were combined into a joint outcome variable. Thus, this variable incorporates SLEs during the child's first 2 months and/or 2 years of life. Analysis was also performed on a combined variable constructed to indicate if any of the respective questions had been indicated as "yes" either during or after pregnancy and combined as "life event during pregnancy" and "life event after pregnancy".

Statistical analysis {#Sec5}
--------------------

Potential covariates were selected a priori from the available data derived from the questionnaires. These were factors with theoretical influence on the impact of SLEs (parental education level, parent born outside of Sweden, and maternal age) or on T1D risk (HLA risk group, first-degree relative diabetes status, and gender). A univariable Cox proportional hazards model was used to assess possible covariates for the multiple regression analysis. Adherence to the proportional hazards assumption for all covariates was analyzed using scaled Schoenfeld residuals. Models fitted including the a priori-selected possible covariates, taking account of the Wald statistic, likelihood ratio, and Akaike information criterion (AIC) for the respective models. The total cohort was then evaluated using a Cox multiple regression model with HLA risk group \[DQ2/8, DQ8/8 or DQ8/X, DQ2/2 or DQ2/X, and DQX/X (X denoting neither 8 nor 2)\], first-degree relative with insulin-dependent diabetes (yes/no), mother born in Sweden (yes/no), and father born in Sweden (yes/no) included as model covariates.

A separate analysis was performed for the high-risk DQ2/8 sub-cohort. Similar to the full cohort, model fit was evaluated using the Wald statistic, likelihood ratio, and model AIC. In this analysis, the final Cox proportional hazards model included only first-degree relative with insulin-dependent diabetes (yes/no) as a covariate. To maximize the use of questionnaire data, all available cases were included in the analysis, and missing data were excluded by pairwise deletion. All cases that had not developed T1D were censored with the date set at November 30, 2017. Statistical analysis was performed using R version 3.4.4 with the Survival (version 2.41) and Survminer (version 0.4.2) packages (R Foundation for Statistical Computing, Vienna, Austria; <https://www.R-project.org>).

Results {#Sec6}
=======

Baseline characteristics {#Sec7}
------------------------

The parents of 23,187 children answered the 2-month questionnaire and 3784 answered the 2-year questionnaire. The mean follow-up for study participants was 15.1 years (SD 1.27 years), and 166 children were diagnosed with T1D in the study cohort. The mean age at T1D diagnosis was 8.54 years (SD 4.03 years) for the 166 children with a T1D diagnosis in the total cohort and 7.71 years (SD 4.08) for the 61 children with T1D in the HLA-DQ2/8 sub-cohort. In the 2-month questionnaire, 4,361 (18.9%) parents reported having experienced an SLE during pregnancy, and 2,311 (10.0%) experienced an SLE during the child's first 2 months of life. In the 2-year questionnaire, 1234 (32.6%) parents reported having experienced SLEs since the last questionnaire was returned. The characteristics of 2-month respondents and 2-year respondents are shown in Table [1](#Tab1){ref-type="table"}. Significant factors entered into a Cox multiple regression analysis included mother born in Sweden (HR 2.4; 95% CI 1.2, 4.8; *p* = 0.016), father born in Sweden (HR 2.97; 95% CI 1.3, 6.7; *p* = 0.009), and first-degree relative with IDDM (HR 6.98; 95% CI 4.3, 11; *p* \< 0.001). All univariate results on both the total and DQ2/8 cohorts are presented in Table [2](#Tab2){ref-type="table"}.

Table 1Characteristics of respondents to the 2-month and 2-year questionnaire2-month questionnaire (*n* = 23,187)2-year questionnaire (*n* = 3861)Maternal age at birthMean (IQR)30.8 (6.0)31.4 (6.0)Male child*n* (%)11,589 (51.6)1899 (52.2)Gestational ageMedian (IQR)39.3 (2.0)39.1 (2.0)First-degree relative IDDM*n* (%)430 (1.9)259 (6.9)HLA DQ2/8*n* (%)865 (3.7)431 (11.4) DQ8/8 or 8/X*n* (%)2163 (9.3)1140 (30.1) DQ2/2 or 2/X*n* (%)1937 (8.4)1016 (26.8) DQ X/X*n* (%)18,190 (78.6)1197 (31.6)Maternal education 9-year compulsory school*n* (%)1412 (6.1)196 (5.2) Senior high school*n* (%)11,611 (50.4)1812 (48.1) College/university*n* (%)10,028 (43.5)1761 (46.5)Paternal education 9-year compulsory school*n* (%)2079 (10.0)336 (9.6) Senior high school*n* (%)11,411 (49.2)1885 (53.7) College/university*n* (%)7379 (35.4)1287 (36.7)Mother born in Sweden*n* (%)20,419 (89.2)3472 (93.0)Father born in Sweden*n* (%)18,553 (88.8)3434 (92.1)Severe life events after birth*n* (%)2311 (10.0)1234 (32.6)

Table 2Hazard ratios for baseline demographic factors in the total and HLA-DQ2/8 cohortTotal cohort (*n* = 23,187)HLA-DQ2/8 cohort (*n* = 865)HR95% CI*p*HR95% CI*p*Maternal age1.000.97:1.00.881.020.97:1.10.48Sex0.770.56:1.10.100.800.48:1.30.39Gestational length^a^0.810.59:1.10.210.950.83:1.10.51Relative birth-weight quartile1.000.99:1.00.970.990.99:1.00.49Maternal education level^b^0.840.65:1.070.160.890.59:1.40.59Paternal education level^b^0.760.59:0.980.0320.700.46:1.10.09Mother born in Sweden2.401.2:4.80.0162.830.69:110.15Father born in Sweden2.971.3:6.70.0091.210.44:3.40.71First-degree relative IDDM^c^6.984.3:11\< 0.0012.541.15:5.60.02HLA haplotype DQ2/842.427:66\< 0.001 DQ8/8 or DQ8/X13.18.2:21\< 0.001 DQ2/2 or DQ2/X7.194.1:13\< 0.001 DQ X/XRefRefRef*Ref* reference level chosen in the analysis^a^Gestational week group (\< 37, 37--40, \> 40 weeks)^b^Education level: Primary school, high school, college, university^c^First-degree relative with diabetes treated with insulin

Severe life events {#Sec8}
------------------

The number and proportion of SLEs for children diagnosed with T1D are shown in Table [3](#Tab3){ref-type="table"}. In the total cohort, there was a significantly increased risk of T1D if the parents reported an SLE between birth and 2 years of age (multiple regression HR 1.67; 95% CI 1.1, 2.7; *p* = 0.03). Kaplan--Meier curves of SLEs after pregnancy for the total cohort including number of subjects at risk is shown in Fig. [2](#Fig2){ref-type="fig"} and for the DQ2/8 cohort in Fig. [3](#Fig3){ref-type="fig"}. There was also an increased risk for children whose parents reported unemployment/conflict in the family or divorce during the child's first 2 years of life (multiple regression HR 2.07; 95% CI 1.01, 4.2; *p* = 0.047). There was no increased risk of T1D in children whose parents had experienced an SLE during pregnancy (multiple regression HR 1.27; 95% CI 0.85, 1.9; *p* = 0.24).

Table 3Hazard ratios for SLE in the total cohort and the HLA-DQ2/8 study cohortExposed to eventUnivariable Cox regressionMultivariable Cox regressionDiabetes cases \[*n* (%)\]Controls \[*n* (%)\]HR95% CI*p*HR95% CI*p*Total cohort^a^ (*n* = 23,187) SLE, during pregnancy38 (22.9)4323 (18.8)1.280.89:1.80.201.270.85:1.90.24 SLE, after pregnancy24 (14.5)2287 (9.9)1.520.99:2.30.061.671.1:2.70.03 SLE, during and/or after pregnancy51 (30.7)5521 (24.0)1.401.00:1.90.0451.390.97:2.00.07 Disease/death/accident/violence, during pregnancy21 (12.6)2451 (10.7)1.210.77:1.90.681.130.69:1.90.62 Disease/death/accident/violence, after pregnancy11 (6.6)1211 (5.3)1.270.69:2.30.571.320.69:2.50.40 Unemployment/conflict/divorce, during pregnancy18 (10.8)1844 (8.0)1.400.86:2.30.181.590.92:2.80.10 Unemployment/conflict/divorce, after pregnancy10 (6.0)898 (3.9)1.580.83:3.00.162.071.01: 4.20.047HLA-DQ 2/8 cohort^b^ (*n* = 865) Serious life event, during pregnancy16 (17.2)156 (18.7)1.450.82:2.60.201.370.76:2.50.29 Serious life event, after pregnancy11 (11.8)71 (8.5)2.191.1:4.20.0192.21.1:4.20.018 Serious life event, during and/or after pregnancy20 (21.5)197 (23.6)1.480.87:2.50.151.410.82:2.40.21 Disease/death/accident/violence, during pregnancy8 (8.6)89 (10.6)1.190.57:2.50.641.050.47:2.30.90 Disease/death/accident/violence, after pregnancy3 (3.2)39 (4.7)1.010.32:3.20.631.000.31:3.20.99 Unemployment/conflict/divorce, during pregnancy10 (10.8)69 (8.2)2.021.0:4.00.0422.161.1:4.30.03 Unemployment/conflict/divorce, after pregnancy7 (7.5)19 (2.3)4.712.1:10\< 0.0014.982.3:11\< 0.001^a^Cox multiple regression model: first-degree relative IDDM, mother born in Sweden, father born in Sweden and HLA risk group included as model covariates^b^Cox multiple regression model: first-degree relative IDDM included as model covariate

Fig. 2Kaplan--Meier curves of SLEs after pregnancy for the total cohort. Survival probability is plotted on the *y*-axis; note that this axis does not start at zero. Log-rank test: *χ*^2^ (1, *n* = 23,187) = 3.7, *p* = 0.055. Gray line: not exposed to event; black line: exposed to event

Fig. 3Kaplan--Meier curves of SLEs after pregnancy for the DQ2/8 cohort. Survival probability is plotted on the *y*-axis; note that this axis does not start at zero. Log-rank test: *χ*^2^ (1, n = 865) = 5.8, *p* = 0.016. Gray line: not exposed to life event; black line: exposed to event

In the DQ2/8 cohort, children with parents reporting an SLE during the child's first 2 years of life had a significantly increased hazard ratio for T1D (HR 2.2; 95% CI 1.1, 4.2; *p* = 0.018), as did those whose parents reported unemployment/conflict in the family or divorce during pregnancy (HR 2.16; 95% CI 1.1, 4.3; *p* = 0.03) or during the child's first 2 years of life (HR 4.98; 2.3, 11; *p* \< 0.001).

Discussion {#Sec9}
==========

In this study, we investigated the effects of self-reported, parental SLEs occurring during pregnancy and early life on T1D risk. There was an increased T1D risk for children in families reporting an SLE during the child's first 2 years of life, both in the population as a whole (HR 1.7) and in individuals with the high-risk HLA DQ2/8 haplotype (HR 2.2). Children whose parents reported unemployment, family conflict, or divorce after pregnancy in both cohorts (total cohort HR 2.1; DQ2/8 cohort HR 4.98) but also during pregnancy in the DQ2/8 cohort were at significantly increased risk of T1D (HR 2.16).

Several studies have examined the relationships between living conditions, stress levels, and immune system function. Chronic or long-term stress is correlated with increased CRP levels \[[@CR11]\], altered cortisol levels \[[@CR6], [@CR7], [@CR24]\], and a dysregulated, pro-inflammatory, immune response \[[@CR4], [@CR8], [@CR25], [@CR26]\]. There is also a correlation between stress levels in parents and levels of cortisol secretion in their young children \[[@CR5], [@CR27], [@CR28]\].

The potential for stress and family SLEs to contribute to autoimmunity or progression to clinical T1D has long been suspected. Stress was proposed to be a major contributor or the main culprit of T1D pathogenesis in early studies \[[@CR3]\], but since then our understanding of the etiology of T1D and islet autoimmunity has increased greatly to reveal a complex, multifactorial pathoetiology \[[@CR29]--[@CR31]\]. Despite this, however, stress and SLE remain potential prenatal and postnatal T1D risk factors.

Prenatal stress has been shown to increase T1D risk \[[@CR32]\], but these results are disputed \[[@CR14]\]. The impact of stress and SLEs on T1D risk has been more thoroughly studied \[[@CR13], [@CR15], [@CR33]\]. Our finding that SLEs occurring during a child's first years of life increase the risk of T1D is consistent with previous studies \[[@CR2], [@CR34]\]. The interpretation of earlier studies on the effects of stress on T1D risk is in many cases hard considering our current understanding of T1D pathoetiology. Many of these earlier studies focused on the near pre-diagnostic period, at which point we can assume that islet autoimmunity and possibly dysglycemia are already established. Hence, the increased risk reported in these studies most likely represents an increase in the progression rate from presymptomatic to symptomatic T1D and not an increase in T1D risk per se \[[@CR35]--[@CR37]\].

In this study, we analyzed both the total available cohort and a sub-cohort comprised only of children with the HLA DQ2/8 high-risk genotype. The rationale for this analysis was threefold. First, we hypothesized that the children at the highest genetic risk of T1D may also be most susceptible to the effects of SLEs. Second, we aimed to create a sub-cohort of children with a homogenous genetic risk profile to minimize the effects of HLA on the results. Third, previously published data did not include HLA risk in the statistical analysis, so this analysis was novel \[[@CR38]\]. Our results indicate that in the HLA DQ2/8 sub-cohort the risk conferred by experiencing an SLE is higher (HR 2.31; *p* = 0.016) than in the total cohort (HR 1.65; *p* = 0.035), with a higher level of significance despite a much smaller number of children in the analysis (total *n* = 23,187; HLA DQ2/8 *n* = 865).

That both the 2-month and 2-year questionnaires were used introduces some bias into the analysis. The questionnaires covered dissimilar timeframes, with 10% of the respondents to the 2-month questionnaire and 33% of the respondents to the 2-year questionnaire reporting SLEs. Additionally, the questionnaires were answered by 23,187 and 3861 families, respectively. The method of data collection must be taken into account in the interpretation of our results.

This study is limited by its reliance on prospectively collected questionnaire data. The DiPiS study protocol did not include a validated questionnaire on parental or child stress, and during the early part of the study no questions were asked regarding whether the child was affected by SLEs and to what degree the child was affected. The use of a validated stress scale would have greatly strengthened the interpretation of the results of this study. Evaluation of psychosocial factors that may affect the impact of negative life events would have improved the weight of the study's results. A measure of quality of life or sense of coherence, both factors that affect the impact of negative life events, would, in hindsight, have been valuable tools to further understand the present results \[[@CR17], [@CR18]\].

The number of SLEs in the cohort was low, despite the fairly large number of participants, weakening the statistical analysis. There were no laboratory data such as cortisol levels or other immune biomarkers to support the results. The 2-month questionnaire was returned by 65% of parents of the originally screened children and the 2-year questionnaire by 49% of parents of the high-risk children invited to participate in the study. However, the latter respondents only amounted to 11% of children initially screened. Regarding the generalizability of the results, the respondents to the 2-month questionnaire were estimated to be similar to the general population but with the usual risk of having an excess of answers from well-functioning families. The same risk applied to the 2-year questionnaire, which was further complicated by this cohort being an at-risk cohort only. These factors need to be accounted for in the interpretation of the results.

Nevertheless, the DiPiS study is a large-scale, prospective follow-up study incorporating a large proportion of at-risk children born between 2000 and 2004 in southern Sweden and is now almost complete with 14 years mean follow-up. This, combined with excellent prevalence data regarding T1D derived from the BDD study, is a major strength of this study. We also analyzed answers from both parents, not only the mother, in contrast to several earlier studies, improving the overall data quality and minimizing data loss due to recall problems.

In conclusion, there was an increased risk of T1D in children whose parents reported being exposed to SLEs during the two first years of life. These data add to our understanding of the potential contribution of stressful events and psychosocial factors to T1D pathoetiology. However, due to the small number of events, the results need to be interpreted with care. To fully understand the effects of stress on autoimmunity and T1D risk, additional well-planned, large-scale studies with validated study questionnaires and laboratory data will be of importance.
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